S&P 500
(-0.32%) 5 218.74 points
Dow Jones
(0.69%) 38 375 points
Nasdaq
(-1.24%) 16 530 points
Oil
(-0.92%) $77.19
Gas
(-0.12%) $2.57
Gold
(-0.80%) $2 347.50
Silver
(-3.37%) $30.47
Platinum
(0.55%) $1 043.70
USD/EUR
(-0.12%) $0.922
USD/NOK
(-0.39%) $10.50
USD/GBP
(0.01%) $0.786
USD/RUB
(0.15%) $90.40

Realtime updates for Ipca Laboratories Limited [IPCALAB.NS]

Exchange: NSE Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Last Updated31 May 2024 @ 06:00

-7.78% INR 1 152.15

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 06:00):

Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India...

Stats
Today's Volume 2.42M
Average Volume 491 013
Market Cap 292.31B
EPS INR0 ( 2024-05-27 )
Next earnings date ( INR0 ) 2024-08-07
Last Dividend INR4.00 ( 2022-11-22 )
Next Dividend INR0 ( N/A )
P/E 53.61
ATR14 INR1.645 (0.14%)

Volume Correlation

Long: -0.24 (neutral)
Short: 0.55 (weak)
Signal:(59.022) Neutral

Ipca Laboratories Limited Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ipca Laboratories Limited Correlation - Currency/Commodity

The country flag 0.38
( neutral )
The country flag 0.25
( neutral )
The country flag 0.42
( neutral )
The country flag -0.09
( neutral )
The country flag 0.02
( neutral )
The country flag -0.19
( neutral )

Ipca Laboratories Limited Financials

Annual 2023
Revenue: INR77.05B
Gross Profit: INR30.64B (39.76 %)
EPS: INR21.57
FY 2023
Revenue: INR77.05B
Gross Profit: INR30.64B (39.76 %)
EPS: INR21.57
FY 2022
Revenue: INR62.44B
Gross Profit: INR39.38B (63.06 %)
EPS: INR18.58
FY 2022
Revenue: INR57.66B
Gross Profit: INR36.60B (63.48 %)
EPS: INR34.85

Financial Reports:

No articles found.

Ipca Laboratories Limited Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR0
(N/A)
INR4.00
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)

Ipca Laboratories Limited Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 9.76 - good (97.61%) | Divividend Growth Potential Score: 2.80 - Decrease likely (43.91%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR0.150 1999-11-24
Last Dividend INR4.00 2022-11-22
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 40 --
Total Paid Out INR32.15 --
Avg. Dividend % Per Year 0.20% --
Score 2.86 --
Div. Sustainability Score 9.76
Div.Growth Potential Score 2.80
Div. Directional Score 6.28 --
Next Divdend (Est)
(2024-11-15)
INR0 Estimate 0.00 %
Dividend Stability
0.08 Very Bad
Dividend Score
2.86
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
1999 INR0 0.00%
2000 INR0 0.00%
2001 INR0 0.00%
2002 INR0 0.00%
2003 INR0 0.00%
2004 INR0 0.00%
2005 INR0 0.00%
2006 INR0 0.00%
2007 INR0 0.00%
2008 INR0 0.00%
2009 INR0 0.00%
2010 INR0 0.00%
2011 INR0 0.00%
2012 INR0 0.00%
2013 INR0 0.00%
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR0.500 0.14%
2019 INR1.500 0.37%
2020 INR6.50 1.14%
2021 INR4.00 0.37%
2022 INR4.00 0.37%
2023 INR0 0.00%
2024 INR0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
TVTODAY.NS Dividend King 2023-09-14 Annually 21 7.90%
PIDILITIND.NS Dividend Knight 2023-07-27 Annually 23 0.29%
JAYAGROGN.NS Dividend Knight 2023-07-07 Annually 23 1.14%
DABUR.NS Dividend Knight 2023-07-21 Semi-Annually 23 0.49%
SOLARINDS.NS Dividend Knight 2023-06-09 Annually 19 0.22%
MGEL.NS Dividend Junior 2023-08-08 Annually 5 0.59%
GSFC.NS Dividend Knight 2023-09-07 Annually 28 2.79%
BANARISUG.NS Dividend Junior 2023-08-28 Annually 22 0.34%
PUNJABCHEM.NS Dividend Junior 2023-07-27 Sporadic 18 0.16%
KARURVYSYA.NS Dividend Junior 2023-08-07 Annually 24 1.32%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.07101.5008.5810.00[0 - 0.5]
returnOnAssetsTTM0.04931.2008.3610.00[0 - 0.3]
returnOnEquityTTM0.08431.500-0.174-0.261[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM2.350.8003.242.59[1 - 3]
quickRatioTTM1.0830.8008.346.67[0.8 - 2.5]
cashRatioTTM0.1261.500-0.411-0.617[0.2 - 2]
debtRatioTTM0.126-1.5007.90-10.00[0 - 0.6]
interestCoverageTTM6.221.0008.818.81[3 - 30]
operatingCashFlowPerShareTTM25.912.001.3642.73[0 - 30]
freeCashFlowPerShareTTM25.912.0010.0010.00[0 - 20]
debtEquityRatioTTM0.221-1.5009.12-10.00[0 - 2.5]
grossProfitMarginTTM0.5931.0003.463.46[0.2 - 0.8]
operatingProfitMarginTTM0.1121.0009.779.77[0.1 - 0.6]
cashFlowToDebtRatioTTM0.4701.0008.508.50[0.2 - 2]
assetTurnoverTTM0.6940.8008.706.96[0.5 - 2]
Total Score9.76

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM56.211.0004.420[1 - 100]
returnOnEquityTTM0.08432.50-0.112-0.261[0.1 - 1.5]
freeCashFlowPerShareTTM25.912.001.36410.00[0 - 30]
dividendYielPercentageTTM0.1651.5005.880[0 - 0.4]
operatingCashFlowPerShareTTM25.912.001.3642.73[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM3.961.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.08531.000-0.3680[0.1 - 0.5]
Total Score2.80

Ipca Laboratories Limited Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Ipca Laboratories Limited

Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetology, gastroenterology, haematology, neurology, ophthalmology, rheumatology, and urology, as well as respiratory, psychiatry, probiotics, orthopedics, oral anti diabetes drug, nutraceuticals, NSAIDs, neuropathic pain, malaria, infectious diseases, immunosuppressant, hepatoprotectives, helminthics, fever, and emollients/protectives. It exports its products to approximately 100 countries worldwide. The company was incorporated in 1949 and is based in Mumbai, India.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.8936660289764 seconds
Number of API calls: 2
Number of DB calls: 8